Kouros Kangarli
FDA investigator
Appears on 3 documents from 2019 to 2021, mostly at sites in California. Most often cites written procedures; deviations (21 CFR 211.100(a)).
- 3
- Documents on file
- 4.3
- Observations per 483
- 2019
- First seen
- 2021
- Most recent
What they cite most
From 13 observations- 21 CFR 211.100(a)Written procedures; deviations2
- 21 CFR 211.103Calculation of yield1
- 21 CFR 211.111Time limitations on production1
- 21 CFR 211.134(b)Drug product inspection1
- 21 CFR 211.160(b)General requirements1
- 21 CFR 211.188(b)Batch production and control records1
Activity by year
2019: 1, 2021: 2
Where
California 3
Often inspects with
Is Kouros Kangarli coming to your site?
Our team writes custom reports before an inspection: what this investigator cites most, how they write it up, and how your site's history compares, in one brief you can circulate.
Ask about any investigator in Claude or ChatGPT with the AI connector.
Inspection history
3 documents, newest first| Date | Firm | Location | Observations | Open |
|---|---|---|---|---|
| 2021-04-14 | 483 Cosmetic Group USA, Inc.Apr 14, 2021 · Pacoima, California | Pacoima, California | 4 | |
| 2021-03-12 | 483 AIRGAS USA, LLCMar 12, 2021 · Ventura, California | Ventura, California | 1 | |
| 2019-12-12 | 483 DLC Laboratories, Inc.Dec 12, 2019 · Paramount, California | Paramount, California | 8 |
About this profile
What does Kouros Kangarli inspect?
Kouros Kangarli appears on 3 documents on file covering 3 sites, mostly in California.
What do they cite most often?
21 CFR 211.100(a) (written procedures; deviations), followed by 21 CFR 211.103 and 21 CFR 211.111.
Can I read the observations?
Each document page previews the opening words of every observation. The full documents are available to buy, one at a time or together.
How current is this profile?
The most recent document on file for Kouros Kangarli is dated Apr 14, 2021.